No article text was recorded for this version.
viral entry inhibition
Version 1 of 136 papers63 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Nuclear shuttling of CDC4 mediated broad-spectrum antiviral activity against diverse coronaviruses
- Blog: Interferon-induced transmembrane protein-1 competitively blocks Ephrin receptor A2-mediated Epstein–Barr virus entry into epithelial cells
- Blog: Decoy peptides effectively inhibit the binding of SARS-CoV-2 to ACE2 on oral epithelial cells
- Blog: Regulation of Epithelial Sodium Transport by SARS-CoV-2 Is Closely Related with Fibrinolytic System-Associated Proteins
- Blog: LINC01197 inhibits influenza A virus replication by serving as a PABPC1 decoy
- Blog: Cyclophilin E Functions as a Negative Regulator to Influenza Virus Replication by Impairing the Formation of the Viral Ribonucleoprotein Complex
- Blog: Hantaviruses use the endogenous host factor P58IPK to combat the PKR antiviral response
- Blog: Prediction of HIV-1 virus-host protein interactions using virus and host sequence motifs
- Blog: TRAF3 activates STING-mediated suppression of EV-A71 and target of viral evasion
- Blog: Potential inhibitors for blocking the interaction of the coronavirus SARS-CoV-2 spike protein and its host cell receptor ACE2
- Blog: Discovery of Novel and Highly Potent Inhibitors of SARS CoV-2 Papain-Like Protease Through Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, Molecular Dynamics Simulations, and Biological Evaluation
- Blog: Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases
- Blog: DNA-Sensing Antiviral Innate Immunity in Poxvirus Infection
- Blog: MxB Disrupts Hepatitis C Virus NS5A–CypA Complex: Insights From a Combined Theoretical and Experimental Approach
- Blog: The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy
- Blog: Triterpenoidal Saponins from the Leaves of Aster koraiensis Offer Inhibitory Activities against SARS-CoV-2
- Blog: Increased Expression of sST2 in Early HIV Infected Patients Attenuated the IL-33 Induced T Cell Responses
- Blog: Platycodin D, a natural component of Platycodon grandiflorum, prevents both lysosome- and TMPRSS2-driven SARS-CoV-2 infection by hindering membrane fusion
- Blog: Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses
- Blog: Potential mechanism of action of Jing Fang Bai Du San in the treatment of COVID-19 using docking and network pharmacology
- Blog: Synthetic Host Defense Peptides Inhibit Venezuelan Equine Encephalitis Virus Replication and the Associated Inflammatory Response
- Blog: Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors
- Blog: Unique and complementary suppression of cGAS-STING and RNA sensing- triggered innate immune responses by SARS-CoV-2 proteins
- Blog: Porcine deltacoronavirus nonstructural protein 2 inhibits type I and III IFN production by targeting STING for degradation
- Blog: Negatively charged peptide nanofibrils from immunoglobulin light chain sequester viral particles but lack cell-binding and viral transduction-enhancing properties
- Blog: An Efficient Modern Strategy to Screen Drug Candidates Targeting RdRp of SARS-CoV-2 With Potentially High Selectivity and Specificity
- Blog: Antiviral drugs arbidol and interferon alpha-1b contribute to reducing the severity of COVID-19 patients: a retrospective cohort study
- Blog: Evolution of enhanced innate immune evasion by SARS-CoV-2
- Blog: Polypharmacology of ambroxol in the treatment of COVID-19
- Blog: Emerging Role for Acyl-CoA Binding Domain Containing 3 at Membrane Contact Sites During Viral Infection
- Blog: The mRNA and protein of IL-8 oppositely regulate PRRSV replication via nucleoprotein and 14-3-3γ
- Blog: Intranasal mask for protecting the respiratory tract against viral aerosols
- Blog: Discovery of Small-Molecule Inhibitors of SARS-CoV-2 Proteins Using a Computational and Experimental Pipeline
- Blog: Discovery of SARS-CoV-2 papain-like protease inhibitors through machine learning and molecular simulation approaches
- Blog: In Vivo Delivery of Adenoviral Vector Containing Interleukin-17 Receptor A Reduces Cardiac Remodeling and Improves Myocardial Function in Viral Myocarditis Leading to Dilated Cardiomyopathy
- Blog: Role of Curcumin in Chronic Liver Diseases: A Comprehensive Review
History & citation
Current · Permanent link
- Competitive Disruption of Viral Protein Interactions merged into this direction (69% overlap)
- Biomimetic Decoys for Viral Interception merged into this direction (54% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_viral_entry_inhibition_8178a372,
title = {viral entry inhibition},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/viral-entry-inhibition/rdr_8178a3721f2941168e6f38ec90b3637d},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-21},
}This exact version (version 1, frozen text):
@misc{lacuna_viral_entry_inhibition_8178a372_v1,
title = {viral entry inhibition},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/viral-entry-inhibition/rdr_8178a3721f2941168e6f38ec90b3637d/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-21},
}